Propanc Biopharma, Inc. (PPCB) stock
PPCBNasdaqPharmaceutical PreparationsFiscal year ends June 30
$1.76−0.12 (-6.38%)
Close on Nov 18, 2026Market cap $1.73MP/E –Yield –
Propanc Biopharma free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Propanc Biopharma's free cash flow for the twelve months ending Jun 30, 2026 was -$5.69M. For fiscal 2026 it was -$5.69M. The highest annual figure on record is -$226.44K in fiscal 2014.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | -$5.69M | – |
| FY2019 | Jun 30, 2019 | -$2.06M | – |
| FY2016 | Jun 30, 2016 | -$4.51M | – |
| FY2015 | Jun 30, 2015 | -$1.43M | – |
| FY2014 | Jun 30, 2014 | -$226.44K | – |
| FY2011 | Jun 30, 2011 | -$1.40M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2026CQ2 2026 | Jun 30, 2026 | -$1.60M | – |
| Q3 FY2026CQ1 2026 | Mar 31, 2026 | -$1.14M | – |
| Q2 FY2026CQ4 2025 | Dec 31, 2025 | -$1.00M | – |
| Q1 FY2026CQ3 2025 | Sep 30, 2025 | -$1.94M | – |
| Q4 FY2019CQ2 2019 | Jun 30, 2019 | -$266.23K | – |
| Q3 FY2019CQ1 2019 | Mar 31, 2019 | -$738.23K | – |
| Q2 FY2017CQ4 2016 | Dec 31, 2016 | -$321.03K | – |
See a number that looks wrong?